{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:12:43Z","timestamp":1761894763232},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,8,29]],"date-time":"2008-08-29T00:00:00Z","timestamp":1219968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1479-5876-6-47","type":"journal-article","created":{"date-parts":[[2008,8,29]],"date-time":"2008-08-29T18:14:00Z","timestamp":1220033640000},"source":"Crossref","is-referenced-by-count":24,"title":["'Aspirin resistance' or treatment non-compliance: Which is to blame for cardiovascular complications?"],"prefix":"10.1186","volume":"6","author":[{"given":"Eduard","family":"Shantsila","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory YH","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,29]]},"reference":[{"key":"277_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists Collaboration","year":"2002","unstructured":"Antithrombotic Trialists Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002, 324: 71-86. 10.1136\/bmj.324.7336.S71.","journal-title":"BMJ"},{"key":"277_CR2","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/j.1538-7836.2005.01351.x","volume":"3","author":"AD Michelson","year":"2005","unstructured":"Michelson AD, Cattaneo M, Eikelboom JW, Gurbel P, Kottke-Marchant K, Kunicki TJ, Pulcinelli FM, Cerletti C, Rao AK, Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society onThrombosis and Haemostasis, Working Group on Aspirin Resistance: Aspirin resistance: position paper of the Working Group on Aspirin Resistance. J Thromb Haemost. 2005, 3: 1309-11. 10.1111\/j.1538-7836.2005.01351.x.","journal-title":"J Thromb Haemost"},{"key":"277_CR3","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.jacc.2005.03.017","volume":"45","author":"SR Steinhubl","year":"2005","unstructured":"Steinhubl SR, Charnigo R, Moliterno DJ: Resistance to antiplatelet resistance. J Am Coll Cardiol. 2005, 45: 1757-1758. 10.1016\/j.jacc.2005.03.017.","journal-title":"J Am Coll Cardiol"},{"key":"277_CR4","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/j.jacc.2007.11.080","volume":"51","author":"AY Gasparyan","year":"2008","unstructured":"Gasparyan AY, Watson T, Lip GY: The role of aspirin in cardiovascular prevention: implications of aspirin resistance. J Am Coll Cardiol. 2008, 51: 1829-43. 10.1016\/j.jacc.2007.11.080.","journal-title":"J Am Coll Cardiol"},{"key":"277_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ahj.2006.10.040","volume":"153","author":"MM Hovens","year":"2007","unstructured":"Hovens MM, Snoep JD, Eikenboom JC, Bom van der JG, Mertens BJ, Huisman MV: Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review. Am Heart J. 2007, 153: 175-81. 10.1016\/j.ahj.2006.10.040.","journal-title":"Am Heart J"},{"key":"277_CR6","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.jacc.2005.06.058","volume":"46","author":"AO Maree","year":"2005","unstructured":"Maree AO, Curtin RJ, Dooley M, Conroy RM, Crean P, Cox D, Fitzgerald DJ: Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease. J Am Coll Cardiol. 2005, 46: 1258-63. 10.1016\/j.jacc.2005.06.058.","journal-title":"J Am Coll Cardiol"},{"key":"277_CR7","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa003199","volume":"345","author":"F Catella-Lawson","year":"2001","unstructured":"Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, DeMarco S, Tournier B, Vyas SN, FitzGerald GA: Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med. 2001, 345: 1809-17. 10.1056\/NEJMoa003199.","journal-title":"N Engl J Med"},{"key":"277_CR8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1160\/TH03-12-0758","volume":"92","author":"DA Payne","year":"2004","unstructured":"Payne DA, Jones CI, Hayes PD, Webster SE, Ross Naylor A, Goodall AH: Platelet inhibition by aspirin is diminished in patients during carotid surgery: a form of transient aspirin resistance?. Thromb Haemost. 2004, 92: 89-96.","journal-title":"Thromb Haemost"},{"key":"277_CR9","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1161\/01.CIR.0000081770.51929.5A","volume":"108","author":"N Zimmermann","year":"2003","unstructured":"Zimmermann N, Wenk A, Kim U, Kienzle P, Weber AA, Gams E, Schr\u00f6r K, Hohlfeld T: Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Circulation. 2003, 108: 542-7. 10.1161\/01.CIR.0000081770.51929.5A.","journal-title":"Circulation"},{"key":"277_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1067\/mcp.2003.1","volume":"73","author":"MK Halushka","year":"2003","unstructured":"Halushka MK, Walker LP, Halushka PV: Genetic variation in cyclooxygenase 1: effects on response to aspirin. Clin Pharmacol Ther. 2003, 73: 122-30. 10.1067\/mcp.2003.1.","journal-title":"Clin Pharmacol Ther"},{"key":"277_CR11","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1161\/01.STR.25.12.2331","volume":"25","author":"CM Helgason","year":"1994","unstructured":"Helgason CM, Bolin KM, Hoff JA, Winkler SR, Mangat A, Tortorice KL, Brace LD: Development of aspirin resistance in persons with previous ischemic stroke. Stroke. 1994, 25: 2331-6.","journal-title":"Stroke"},{"key":"277_CR12","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jacc.2003.08.062","volume":"43","author":"FM Pulcinelli","year":"2004","unstructured":"Pulcinelli FM, Pignatelli P, Celestini A, Riondino S, Gazzaniga PP, Violi F: Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients. J Am Coll Cardiol. 2004, 43: 979-84. 10.1016\/j.jacc.2003.08.062.","journal-title":"J Am Coll Cardiol"},{"key":"277_CR13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1055\/s-0037-1615048","volume":"79","author":"J Maclouf","year":"1998","unstructured":"Maclouf J, Folco G, Patrono C: Eicosanoids and iso-eicosanoids: constitutive, inducible and transcellular biosynthesis in vascular disease. Thromb Haemost. 1998, 79: 691-705.","journal-title":"Thromb Haemost"},{"key":"277_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/08964289809596379","volume":"24","author":"RM Carney","year":"1998","unstructured":"Carney RM, Freedland KE, Eisen SA, Rich MW, Skala JA, Jaffe AS: Adherence to a prophylactic medication regimen in patients with symptomatic versus asymptomatic ischemic heart disease. Behav Med. 1998, 24: 35-39.","journal-title":"Behav Med"},{"key":"277_CR15","first-page":"2339","volume":"140","author":"J Tarj\u00e1n","year":"1999","unstructured":"Tarj\u00e1n J, Salamon A, J\u00e1ger R, Po\u00f3r F, Barczi V, Dinny\u00e9s J, Hamvas J, Kinczel A, P\u00e1l A, Blask\u00f3 G: The rate of acetylsalicylic acid non-respondents among patients hospitalized for acute coronary disease, previously undergoing secondary salicylic acid prophylaxis. Orv Hetil. 1999, 140: 2339-43.","journal-title":"Orv Hetil"},{"key":"277_CR16","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.amjcard.2004.12.038","volume":"95","author":"KA Schwartz","year":"2005","unstructured":"Schwartz KA, Schwartz DE, Ghosheh K, Reeves MJ, Barber K, Defranco A: Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction. Am J Cardiol. 2005, 95: 973-75. 10.1016\/j.amjcard.2004.12.038.","journal-title":"Am J Cardiol"},{"key":"277_CR17","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1161\/01.STR.25.12.2337","volume":"25","author":"T Komiya","year":"1994","unstructured":"Komiya T, Kudo M, Urabe T, Mizuno Y: Compliance with antiplatelet therapy in patients with ischemic cerebrovascular disease. Assessment by platelet aggregation testing. Stroke. 1994, 25: 2337-42.","journal-title":"Stroke"},{"key":"277_CR18","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1001\/archinte.166.17.1842","volume":"166","author":"PM Ho","year":"2006","unstructured":"Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ, Krumholz HM, Rumsfeld JS: Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006, 166: 1842-7. 10.1001\/archinte.166.17.1842.","journal-title":"Arch Intern Med"},{"key":"277_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ahj.2003.07.011","volume":"147","author":"G Cotter","year":"2004","unstructured":"Cotter G, Shemesh E, Zehavi M, Dinur I, Rudnick A, Milo O, Vered Z, Krakover R, Kaluski E, Kornberg A: Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?. Am Heart J. 2004, 147: 293-300. 10.1016\/j.ahj.2003.07.011.","journal-title":"Am Heart J"},{"key":"277_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","volume":"336","author":"G Krasopoulos","year":"2008","unstructured":"Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR: Aspirin \"resistance\" and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ. 2008, 336: 195-8. 10.1136\/bmj.39430.529549.BE.","journal-title":"BMJ"},{"key":"277_CR21","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.jacc.2005.05.090","volume":"46","author":"US Tantry","year":"2005","unstructured":"Tantry US, Bliden KP, Gurbel PA: Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. J Am Coll Cardiol. 2005, 46: 1705-9. 10.1016\/j.jacc.2005.05.090.","journal-title":"J Am Coll Cardiol"},{"key":"277_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ahj.2003.07.011","volume":"147","author":"G Cotter","year":"2004","unstructured":"Cotter G, Shemesh E, Zehavi M, Dinur I, Rudnick A, Milo O, Vered Z, Krakover R, Kaluski E, Kornberg A: Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?. Am Heart J. 2004, 147: 293-300. 10.1016\/j.ahj.2003.07.011.","journal-title":"Am Heart J"},{"key":"277_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1479-5876-6-46","volume":"6","author":"KA Schwartz","year":"2008","unstructured":"Schwartz KA, Schwartz DE, Barber K, Reeves M, De Franco AC: Non-Compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients. J Transl Med. 2008, 6: 46-10.1186\/1479-5876-6-46.","journal-title":"J Transl Med"},{"key":"277_CR24","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1160\/TH05-12-0808","volume":"95","author":"S Wong","year":"2006","unstructured":"Wong S, Morel-Kopp MC, Chen Q, Appleberg M, Ward CM, Lewis DR: Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease. Thromb Haemost. 2006, 95: 1042-3.","journal-title":"Thromb Haemost"},{"key":"277_CR25","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1056\/NEJMra052717","volume":"353","author":"C Patrono","year":"2005","unstructured":"Patrono C, Garc\u00eda Rodr\u00edguez LA, Landolfi R, Baigent C: Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med. 2005, 353: 2373-83. 10.1056\/NEJMra052717.","journal-title":"N Engl J Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-6-47.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1479-5876-6-47\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-6-47.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T05:37:00Z","timestamp":1548135420000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-6-47"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,29]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["277"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-6-47","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,29]]},"article-number":"47"}}